Oral delivery of macromolecules

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6656922
SERIAL NO

09845827

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Polysaccharides, which are widely used as an anticoagulation drugs, especially heparin, are clinically administered only by intravenous or subcutaneous injection because of their strong hydrophilicity and high negative charge. Amphiphilic heparin derivatives were synthesized by conjugation to bile acids, sterols, and alkanoic acids, respectively. These heparin derivatives were slightly hydrophobic, exhibited good solubility in water, and have high anticoagulation activity. These slightly hydrophobic heparin derivatives are efficiently absorbed in the gastrointestinal tract and can be used in oral dosage forms. Methods of using these amphiphilic heparin derivatives and similarly modified macromolecules for oral administration are also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDIPLEX CORPORATION27TH FLOOR KOREA WORLD TRADE CENTER 159-1 SAMSUNG-DONG KANGNAM-KU SEOUL 135-7

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Byun, Youngro Gwangju, KR 21 439
Lee, Yong-Kyu Gwangju, KR 80 1441

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation